Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGNX vs MKSI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGNX Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–5 Matrix Metrics)

CGNX Overall Winner 6-Pillar Tally: CGNX 3 – 3 MKSI Matrix Metrics: CGNX 5 – 5 MKSI

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over MKS Inc. (MKSI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas MKSI carries 42.7/100 (HOLD) at $204.50 (10.9x Forward P/E, 18.9% operating margin).

  • Growth vs. Quality Trade-Off: CGNX earns the overall head-to-head edge with a stronger Unified Composite Score (59.5/100 HOLD vs. MKSI 42.7/100 HOLD) and 2.19β · 65% Vol risk profile, whereas MKSI leads top-line expansion (+43.0% YoY revenue growth, 1.32x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile MKSI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNX vs MKSI
CGNX NASDAQ Head-to-Head Winner
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap $8.5B
TTM Revenue $1.13B
Forward P/E 24.7x
Beta / 30D Vol 2.19β · 65% Vol
Unified Composite Score
59.5 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $53.86 · SMA50: $57.80
MKSI NASDAQ
MKS Inc. Common Stock
Industrial Instruments For Measurement, Display, And Control
$204.50
-5.17% 1D
Market Cap $15.0B
TTM Revenue $4.77B
Forward P/E 10.9x
Beta / 30D Vol 2.93β · 84% Vol
Unified Composite Score
42.7 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 59.0 Mom 58.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.9%), weak momentum, RSI 44
RSI-14: 44.3 · SMA20: $206.49 · SMA50: $235.61

6-Pillar Scorecard Institutional Category Breakdown (CGNX 3 – 3 MKSI)

Columns: Metric · CGNX · MKSI
1. Valuation Multiples MKSI
Forward P/E 24.7x 10.9x
Trailing P/E 35.5x 26.2x
PEG Ratio 2.71x 1.32x
EV / Revenue 7.0x 3.8x
2. Growth & Scale MKSI
Revenue Growth (YoY) +13.2% +43.0%
Earnings Growth (YoY) +400.0% +196.5%
TTM Revenue (USD) $1.13B $4.77B
Market Cap $8.5B $15.0B
3. Profitability & Quality CGNX
Gross Margin 69.7% 47.3%
Operating Margin 25.0% 18.9%
Net Profit Margin 21.5% 12.6%
Return on Equity (ROE) 15.1% 20.5%
4. Balance Sheet & Cash Flow CGNX
Cash Generation (TTM) $286M $552M
Cash Flow Margin 25.4% 11.6%
Net Cash / Leverage $624M Net Cash $3.34B Net Debt (1.22x D/E)
Dividend Yield 0.66% 0.43%
5. Options & Positioning MKSI
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 53.5% (16th %ile) 61.0% (2nd %ile)
Put/Call OI Skew 1.96x (Put-Skewed) 3.99x (Put-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markdown ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat CGNX
OpEx & R&D Intensity 44.7% of Rev ($503M) 28.4% of Rev ($1.36B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNX (5) vs MKSI (5)
Institutional Metric CGNX MKSI Criterion Row Edge
Market Capitalization
Scale
$8.5B $15.0B Larger Scale MKSI
Trailing P/E Ratio
Valuation
35.5x 26.2x Lower Multiple MKSI
Forward P/E Ratio
Valuation
24.7x 10.9x Lower Multiple MKSI
Revenue Growth (YoY)
Growth
+13.2% +43.0% Higher Growth MKSI
Operating Margin (TTM)
Profitability
25.0% 18.9% Higher Margin CGNX
Net Profit Margin
Profitability
21.5% 12.6% Higher Margin CGNX
Return on Equity (ROE)
Capital Efficiency
15.1% 20.5% Higher ROE MKSI
52-Week Range Position
Momentum
35% ($35–$73) 22% ($135–$448) Stronger Trend CGNX
Beta / 30D Volatility
Risk Regime
2.19β · 65% Vol 2.93β · 84% Vol Lower Realized Risk CGNX
Unified Institutional Score
Composite Signal
59.5 / 100 (HOLD) 42.7 / 100 (HOLD) Higher Composite CGNX
Trailing 12M Revenue (USD)
Operating Scale
$1.13B $4.77B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.7% 47.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.71x PEG · 7.0x EV/Rev 1.32x PEG · 3.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$286M ($624M Net Cash) $552M ($3.34B Net Debt (1.22x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MKSI +6.17 pp
CGNX: -10.98% · MKSI: -4.81%
3M Horizon CGNX +7.68 pp
CGNX: -24.21% · MKSI: -31.89%
6M Horizon CGNX +8.47 pp
CGNX: -22.37% · MKSI: -30.84%
1Y Horizon MKSI +12.18 pp
CGNX: +29.72% · MKSI: +41.9%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CGNX Revenue MKSI Revenue CGNX Op. Margin MKSI Op. Margin Margin Leader
FY2018 $810M $2.08B 27.4% 23.8% CGNX
FY2019 $730M $1.90B 19.7% 11.6% CGNX
FY2020 $810M $2.33B 21.0% 19.5% CGNX
FY2021 $1.04B $2.95B 30.4% 23.7% CGNX
FY2022 $1.01B $3.55B 24.5% 17.4% CGNX
FY2023 $840M $3.62B 15.6% -42.9% CGNX
FY2024 $910M $3.59B 12.6% 13.9% MKSI
FY2025 $990M $3.93B 16.3% 13.4% CGNX

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNX BREAKDOWN
121d in phase · OBV ACCUMULATION
Current IV 53.5%
IV Percentile 16th %ile
Put/Call OI Skew 1.96x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MKSI BREAKDOWN
102d in phase · OBV ACCUMULATION
Current IV 61.0%
IV Percentile 2nd %ile
Put/Call OI Skew 3.99x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact MKSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNX Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($503M)
90D Engineering Disclosures 0 Published
MKSI Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $15.0B market capitalization and 18.9% operating margin.
OpEx & R&D Reinvestment 28.4% of Rev ($1.36B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
Analog Devices Texas Instruments Honeywell International Cadence Design Systems

Investor FAQ CGNX vs MKSI Key Questions & Quantitative Answers

As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over MKS Inc. (MKSI) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas MKSI carries 42.7/100 (HOLD) at $204.50 (10.9x Forward P/E, 18.9% operating margin). Growth vs. Quality Trade-Off: CGNX earns the overall head-to-head edge with a stronger Unified Composite Score (59.5/100 HOLD vs. MKSI 42.7/100 HOLD) and 2.19β · 65% Vol risk profile, whereas MKSI leads top-line expansion (+43.0% YoY revenue growth, 1.32x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile MKSI is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MKSI leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with MKSI at +43.0% YoY revenue growth and +196.5% YoY earnings growth on $4.77B TTM revenue (47.3% gross margin, 18.9% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CGNX cumulative revenue shifted +22.2% while MKSI shifted +88.9%. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 28.4% of Rev ($1.36B) (0 disclosures) for MKSI.

MKSI screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas MKSI trades at 10.9x Forward P/E, 26.2x Trailing P/E, 1.32x PEG, and 3.8x EV/Revenue (11.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus MKSI (20.5% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, MKSI carries 61.0% implied volatility (2nd %ile, Compressed (<25th %ile)), a 3.99x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.93β · 84% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.